JPRN-UMIN000002453已完成未知
2nd-line Tarceva+ALIMTA for EGFR mutation negative non-small, non-squamous lung cancer (TALIMTA STUDY) - 2nd-line Tarceva+ALIMTA for EGFR mutation negative non-small, non-squamous lung cancer (TALIMTA STUDY)
Respiratory Medicine, Kyoto University Hospital0 个研究点目标入组 30 人开始时间: 2010年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)previous chemotherapy with erlotinib, gefitinib, or pemetrexed 2)interstitial pneumoia/active lung fibrosis on chest x-ray 3)massive or uncontrolable pleural effusion 4)symptomatic brain metastasis 5)active concomitant malignancy 6)severe comorbidity 7)pregnant or lactating woman 8)history of severe drug allergy 9)psychiatry disease
研究者
相似试验
已完成
2 期
Trimodality therapy in EGFR mutation status negative patients with stage IV non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000006021Iseikai Hospital45
Unknown
2 期
Tarceva With or Without Apatinib in the Advanced Lung AdenocarcinomaLung CancerNCT02704767First Affiliated Hospital of Kunming Medical University60
进行中（未招募）
1 期
Erlotinib treatment beyound progressioocally advanced or metastatic non-small cell lung cancer with activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor or who have responded to EGFR TKIMedDRA version: 14.1Level: LLTClassification code 10025054Term: Lung cancer non-small cell stage IIIBSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864EUCTR2013-002049-13-FIOulu University Hospital
招募中
2 期
Additional chemotherapy for EGFRm patients with the continued presence of plasma ctDNA EGFRm at week 3 after start of osimertinib 1st-line treatment (PACE-Lung)2024-517965-18-00Goethe University Frankfurt, Goethe University Frankfurt400
进行中（未招募）
不适用
Pemetrexed plus tarceva as salvage treatment in EGFR overexpressed metastatic colorectal cancer patients who were failed after standard chemotherapy: A phase II single arm prospective studyNeoplasmsKCT0003757Samsung Medical Center29